Drugs / Ruyizhenbao Pill
Ruyizhenbao Pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04029701 | Jan 2017 → Dec 2019 | — | Guangzhou University of Traditional Chinese Medicine | Unknown | Met primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ruyizhenbao Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04029701 ↗ |
| Known as | Ruyi Zhenbao Pills | “OBJECTIVE: To evaluate the efficacy and safety of Tibetan medicine Ruyi Zhenbao Pills (RZPs) in the treatment of patients with motor and sensory dysfunction after stroke.” PMID 35723814 ↗ Jun 2022 |
| Known as | RZPs | “OBJECTIVE: To evaluate the efficacy and safety of Tibetan medicine Ruyi Zhenbao Pills (RZPs) in the treatment of patients with motor and sensory dysfunction after stroke.” PMID 35723814 ↗ Jun 2022 |
| Modality | Traditional medicine (herbal / TCM) | “Tibetan medicine Ruyi Zhenbao Pills (RZPs)” PMID 35723814 ↗ Jun 2022 |
| Route | Oral | “Medication method: oral 4 pills once, twice a day, 4 weeks in a row.” NCT04029701 ↗ |